Mesothelioma Trial, Recruiting (NCT01950572)

Mesothelioma Trial, Recruiting NCT01950572 Sponsor: National Cancer Institute (NCI) Condition: Mesothelioma

Printed from Voxsanity (voxsanity.com.au) — NCT01950572 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Mesothelioma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 2 years of age or older and have been diagnosed with malignant mesothelioma (a type of cancer affecting the lining of certain organs)
You are 18 years of age or older and have been diagnosed with thymic carcinoma, pancreatic or bile duct cancer, lung cancer, stomach cancer, ovarian cancer, or another solid tumour that is known to produce a protein called mesothelin
Your diagnosis has been confirmed through laboratory testing of tissue samples
You are willing and able to give your consent to take part in the trial

Who may not be able to join:

You have a serious condition affecting a major organ (such as heart disease, a recent heart attack, heart failure, or breathing problems) that could make having a biopsy (tissue sample procedure) more risky
You are currently pregnant
You have another medical or mental health condition that the lead doctor believes could put you at greater risk by taking part in the trial
You are an adult who is unable to give your own informed consent to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raffit Hassan, M.D., National Cancer Institute (NCI)

Phone: (240) 858-3152

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01950572

Sponsor: National Cancer Institute (NCI)

Phase: Not Applicable

Status: Recruiting

Condition: Mesothelioma

Trial contact: (240) 858-3152

More information: https://clinicaltrials.gov/study/NCT01950572

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 2 years of age or older and have been diagnosed with malignant mesothelioma (a type of cancer affecting the lining of certain organs)
You are 18 years of age or older and have been diagnosed with thymic carcinoma, pancreatic or bile duct cancer, lung cancer, stomach cancer, ovarian cancer, or another solid tumour that is known to produce a protein called mesothelin
Your diagnosis has been confirmed through laboratory testing of tissue samples
You are willing and able to give your consent to take part in the trial

Who may not be able to join:

You have a serious condition affecting a major organ (such as heart disease, a recent heart attack, heart failure, or breathing problems) that could make having a biopsy (tissue sample procedure) more risky
You are currently pregnant
You have another medical or mental health condition that the lead doctor believes could put you at greater risk by taking part in the trial
You are an adult who is unable to give your own informed consent to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Institute (NCI)

Registry

ClinicalTrials.gov

Start date

9 September 2013

Est. completion

25 July 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

sample aquisition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov